Breakthroughs for Obese Patients with VTE
| Overview / Abstract: |
What is the latest evidence for VTE prophylaxis and treatment in obese patients and how is this different from the current guidelines? In this activity, expert cardiology faculty cover the most recent data and guideline limitations on VTE prevention and management. Roundtable discussion is included to provide practical insight to help clinicians apply knowledge to their practice. |
|
Expiration |
Feb 26, 2022 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
|
Format |
Online, Webinar / Webcast / Video |
|
Credits / Hours |
.50 AMA PRA Category 1 Credit(s)™ |
|
Accreditation |
ACCME |
|
Presenters / Authors / Faculty |
Gregory Piazza, MD, MS; Christian Ruff, MD, MPH |
|
Sponsors / Supporters / Grant Providers |
This activity is supported by an educational grant from Janssen Scientific Affairs, LLC. |
|
Keywords / Search Terms |
ACHL CME, CME/CE, anticoagulant, anticoagulation, guideline recommendations, prophylactic, DOAC, monotherapy, combination, thrombotic, thrombotic events, VTE, venous, embolism, piazza, ruff, obese, prophylaxis, ISTH, non-valvular, bmi, warfarin Free CE CME |
|